We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDPH
RNS Number : 9585A
Dechra Pharmaceuticals PLC
17 September 2018
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 September 2018
Hot Features
Premium
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Long-Term Incentive Scheme
-----------------------------------------
Period of return: From: 15 March 2018 To: 14 September 2018
----------------------- -------------- ----- ------------------
Balance of unallotted securities under scheme(s) from previous return: 249
-----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 156,000
-----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period Nil
(see LR3.5.7G):
-----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 156,249
-----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814730
-------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 September 2018
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Approved Share Option Scheme
-----------------------------------------
Period of return: From: 15 March 2018 To: 14 September 2018
----------------------- -------------- ----- ------------------
Balance of unallotted securities under scheme(s) from previous return: 22,214
-----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the Nil
date of the last
return (if any increase has been applied for):
-----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 2,745
-----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 19,469
-----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 September 2018
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Unapproved Share Option Scheme
-----------------------------------------
Period of return: From: 15 March 2018 To: 14 September 2018
----------------------- -------------- ----- ------------------
Balance of unallotted securities under scheme(s) from previous return: 73,706
-----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 36,000
-----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 19,266
-----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 90,440
-----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 September 2018
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: SAYE Scheme
-----------------------------------------
Period of return: From: 15 March 2018 To: 14 September 2018
----------------------- -------------- ----- ------------------
Balance of unallotted securities under scheme(s) from previous return: 5,622
-----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 14,000
-----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 5,968
-----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 13,654
-----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRLIFIAALIDLIT
(END) Dow Jones Newswires
September 17, 2018 05:03 ET (09:03 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
